About Intervene
Intervene is a company based in Derby (United Kingdom) founded in 2003.. Intervene has raised $37.59 million across 6 funding rounds from investors including Boston Scientific, Treo Ventures and RiverVest Venture Partners. The company has 11 employees as of December 31, 2022. Intervene offers products and services including Recana TM. Intervene operates in a competitive market with competitors including Tactile Medical, enVVeno Medical, Veniti, Sky Medical Technology and DeVoro Medical, among others.
- Headquarter Derby, United Kingdom
- Employees 11 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Intervene, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$37.59 M (USD)
in 6 rounds
-
Latest Funding Round
$13 M (USD), Series B
Oct 07, 2024
-
Investors
Boston Scientific
& 7 more
-
Employee Count
11
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intervene
Intervene offers a comprehensive portfolio of products and services, including Recana TM. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Engineered to de-bulk and recanalize chronic venous occlusions.
Unlock access to complete
Unlock access to complete
Funding Insights of Intervene
Intervene has successfully raised a total of $37.59M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $13 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $13.0M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series B - Intervene | Valuation | Treo Ventures , RiverVest Venture Partners |
|
| Mar, 2023 | Amount | Series B - Intervene | Valuation |
investors |
|
| Jun, 2019 | Amount | Series B - Intervene | Valuation | 3x5 Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Intervene
Intervene has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Treo Ventures and RiverVest Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on breakthrough healthcare solutions.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Private investments are managed for institutional investors globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Intervene
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Intervene
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intervene Comparisons
Competitors of Intervene
Intervene operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tactile Medical, enVVeno Medical, Veniti, Sky Medical Technology and DeVoro Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Home therapy devices for lymphedema and venous ulcers are provided.
|
|
| domain | founded_year | HQ Location |
Developer of medical device for the the treatment of venous diseases
|
|
| domain | founded_year | HQ Location |
A self-expanding stent system for chronic venous disease is developed.
|
|
| domain | founded_year | HQ Location |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| domain | founded_year | HQ Location |
Medical devices for treating cardiac diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intervene
Frequently Asked Questions about Intervene
When was Intervene founded?
Intervene was founded in 2003 and raised its 1st funding round 6 years after it was founded.
Where is Intervene located?
Intervene is headquartered in Derby, United Kingdom.
Is Intervene a funded company?
Intervene is a funded company, having raised a total of $37.59M across 6 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Jun 01, 2009.
How many employees does Intervene have?
As of Dec 31, 2022, the latest employee count at Intervene is 11.
What does Intervene do?
InterVene was founded in 2003 and is based in Derby, United Kingdom. Medical devices are developed by the company within the healthcare sector, focusing on severe venous disease in the legs. A non-implantable, catheter-based approach is utilized to form new vein valves from native tissue, addressing chronic venous insufficiency. This enables blood to be pumped efficiently from the legs to the heart, shifting care from ongoing management to targeted intervention.
Who are the top competitors of Intervene?
Intervene's top competitors include Tactile Medical, enVVeno Medical and Sky Medical Technology.
What products or services does Intervene offer?
Intervene offers Recana TM.
Who are Intervene's investors?
Intervene has 8 investors. Key investors include Boston Scientific, Treo Ventures, RiverVest Venture Partners, American Century Private Investments, and Correlation Ventures.